antibody-drug conjugates

New funding will support scaling, team expansion, and the launch of customizable solutions for spatial biology, proteomics, and single-cell analysis.

Simtra is positioned to become the first CDMO to offer commercial-scale drug product manufacturing of ADCs in the US, enabling customers to complete the entire supply chain domestically.

Manish Sharma led a clinical trial for a new antibody-drug conjugate that decreased tumor size in patients who had not responded to chemotherapy.

Lantern Pharma kicks off ADC program to develop treatments for various cancer types